Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 18;36(26):3830-3835.
doi: 10.1016/j.vaccine.2018.05.014. Epub 2018 May 31.

An innovative medical school curriculum to address human papillomavirus vaccine hesitancy

Abigail M Schnaith  1 , Erica M Evans  2 , Caleb Vogt  3 , Andrea M Tinsay  4 , Thomas E Schmidt  5 , Katelyn M Tessier  6 , Britt K Erickson  7
Affiliations

An innovative medical school curriculum to address human papillomavirus vaccine hesitancy

Abigail M Schnaith et al. Vaccine. .

Abstract

Background: Vaccination rates against Human Papillomavirus (HPV) in the US remain alarmingly low. Physicians can significantly influence a parent's decision to vaccinate their children. However, medical education often lacks training on specific strategies for communicating with vaccine hesitant parents.

Methods: We created an innovative curriculum designed to teach medical students how to address HPV vaccine hesitancy. The curriculum consisted of (1) a presentation on the epidemiology, biology, and disease morbidity associated with HPV, (2) a video that teaches specific communication strategies and (3) role-playing simulations. This curriculum was delivered to medical students at two separate sites. Medical students were surveyed before and after completing the educational curriculum. The surveys assessed student comfort talking to HPV vaccine hesitant parents and their likelihood to recommend the HPV vaccine.

Results: Pre- and post-intervention surveys were completed by 101 of the 132 participants (77% response rate). After the intervention, student awareness of the benefits of the HPV vaccine increased by a mean of 0.82 points (Likert scale 1-5, p < 0.01) and student comfort talking to vaccine hesitant parents increased by a mean of 1.37 points (p < 0.01). Prior to the intervention, students more strongly recommended the HPV vaccine to females compared to males, but this gender disparity was eliminated after the intervention (p < 0.01). Personal vaccination status was independately associated with a higher likelihood of recommending the HPV vaccine both before and after the intervention.

Conclusion: Our innovative curriculum improved medical student comfort level discussing HPV vaccination with hesitant parents and increased the perceived likelihood of recommending HPV vaccination. The intervention is easy to implement, scalable, and requires minimal resources. Educating future providers on this important topic has the potential to improve vaccination rates nationwide and thus should be considered for all medical students.

Keywords: C.A.S.E. method; Curriculum; HPV vaccine; Human Papillomavirus (HPV); Medical education; Vaccine hesitancy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The authors do not have any commercial or other associations that might pose a conflict of interest.

Figures

Fig. 1.
Fig. 1.
Likert responses for the statement “The C.A.S.E. approach is very useful in talking to HPV hesitant patients/parents”.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Incidence, Prevalence, and Cost of Sexually Transmitted Infections in the United States. Centers for Disease Control and Prevention, National Center for HIV Viral Hepatitis STD and TB Prevention; 2013.
    1. Viens LJ, Henley J, Thom TD. Human papillomavirus-associated cancers United States, 2008–2012. Mmwr-Morbidity Mortality Weekly Report 2016;65:661–6. 10.15585/mmwr.mm6526a1. - DOI - PubMed
    1. Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Mmwr-Morbidity Mortality Weekly Report 2015;64:300–4. - PMC - PubMed
    1. Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years - United States, 2016. Mmwr-Morbidity and Mortality Weekly Report. 2017;66:874–82. 10.15585/mmwr.mm6633a2. - DOI - PMC - PubMed
    1. Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. Jnci-J Nat Cancer Inst 2015;107 10.1093/jnci/djv086. - DOI - PMC - PubMed

Publication types

Substances